Who Owns LTRN?

Lantern Pharma Inc. — Institutional Ownership & 13F Holdings

$2.43

-0.03 (-1.22%)

Market Cap

$29.9M

Shares Outstanding

11,254,697

Institutional Holders

31

Total Inst. Value

$8.6M

% of Float Held

QoQ Holder Change

+2

Institutional data as of Q1 2025

New Positions

3

Closed Positions

4

Increased

10

Decreased

5

Institutional Ownership Trend

Top 10 Institutional Holders(Q1 2025)

#FundValueShares
1BIOS Capital Management, LP$4.3M1,207,709
2VANGUARD GROUP INC$1.3M363,720
3CM Management, LLC$708K200,000
4GEODE CAPITAL MANAGEMENT, LLC$319K90,504
5RENAISSANCE TECHNOLOGIES LLC$314K88,800
6NewEdge Advisors, LLC$212K59,924
7Voss Capital, LP$177K50,000
8BlackRock, Inc.$142K40,248
9Perigon Wealth Management, LLC$139K39,387
10DIMENSIONAL FUND ADVISORS LP$133K37,483

Biggest Buyers & Sellers This Quarter

Famous Fund Managers

Related Stocks

Frequently Asked Questions

How many institutional investors hold LTRN?

As of Q1 2025, 31 institutional investors report holding LTRN (Lantern Pharma Inc.) in their 13F filings.

Which hedge fund owns the most LTRN?

The largest institutional holder of LTRN is BIOS Capital Management, LP with $4.3M in shares.

Are institutions buying or selling LTRN?

This quarter, 3 institutions opened new positions in LTRN and 4 closed their positions.

What is 13F institutional ownership?

SEC Form 13F is a quarterly report filed by institutional investment managers with over $100M in qualifying assets. It discloses their US equity holdings, providing transparency into what the largest investors are buying and selling.

How often is institutional ownership data updated?

13F filings are due 45 days after each calendar quarter end (May 15, Aug 14, Nov 14, Feb 14). Data is updated on HedgeTrace as new filings are processed.